Sellas Life Sciences Group Inc (SLS)
Investing Cash Flow
$0.00
TTM · Period ending: · USD

SLS Investing Cash Flow
Latest reported$0.00period ending
Latest reported$0.00period ending
SLS TTM Cash from Investing (-$10.03M → $0.00)
TTM investing cash flow
High-resolution chart · PNG
SLS investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -3,000,000 | |
| -5,500,000 | |
| -5,500,000 | |
| -5,500,000 | |
| -7,000,000 | |
| -9,000,000 | |
| -9,000,000 | |
| -9,000,000 | |
| -4,500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,812,000 | |
| 1,837,000 | |
| 1,830,000 | |
| 1,812,000 | |
| 1,050,000 | |
| 2,075,000 | |
| 1,032,000 | |
| -6,000 | |
| 10,155,000 | |
| 8,858,000 | |
| 9,857,000 | |
| 10,395,000 | |
| -925,000 | |
| -3,753,000 | |
| -4,014,000 | |
| -5,528,000 | |
| -8,219,000 | |
| -4,424,000 | |
| -3,981,000 | |
| -12,036,000 | |
| -9,323,000 | |
| -10,043,000 | |
| -10,261,000 | |
| -174,000 | |
| -188,000 | |
| -188,000 | |
| 54,000 | |
| 14,000 | |
| 6,064,000 | |
| 6,059,000 | |
| -132,000 | |
| -106,000 | |
| -5,972,000 | |
| -6,003,000 | |
| -6,000 | |
| 0 | |
| 8,823,000 | |
| 5,882,000 | |
| -170,000 | |
| 9,600,000 | |
| 2,499,000 | |
| -6,335,000 | |
| -262,000 | |
| -10,025,000 | |
| -11,830,000 |